Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy

被引:3
作者
Ninichuk, V. [1 ]
Kulkarni, O. [1 ]
Clauss, S. [1 ]
Anders, H.-J. [1 ]
机构
[1] Univ Munich, Med Poliklin, D-80336 Munich, Germany
关键词
kidney; diabetes; progression; mice;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: Advanced diabetic nephropathy (DN) is difficult to address experimentally in mice because available models of DN lack global glomerulosclerosis and major tubulointerstitial pathology. Accelerating the development of DN in mice would be desirable for feasible experimental validation of potential targets that mediate the progression to late stage DN. Methods: 6 week old male db/db mice underwent uninephrectomy and the development of nephropathy was compared to wild-type mice and sham-operated db/db mice. Results: Uninephrectomy at young age was associated with increased albuminuria and severe glomerulosclerosis in 37% of glomeruli at 24 weeks of age as compared to sham-operated db/db mice (8%). Uninephrectomy also increased the number of glomerular macrophages in db/db mice. The uninephrectomy-related acceleration of glomerular damage was associated with significant tubulointerstitial injury as indicated by an increase in indices of tubular cell damage, tubular dilatation, and expansion of interstitial volume. Uninephrectomy markedly increased the renal mRNA expression of Mcp-1/Ccl2, Tgf-beta, and collagen I. Conclusion: Early uninephrectomy can accelerate the development of advanced DN in db/db mice which may be instrumental in the design of interventional studies that intend to focus on the molecular pathology of the progression to late stage DN.
引用
收藏
页码:351 / 355
页数:5
相关论文
共 10 条
  • [1] Use of genetic mouse models in the study of diabetic nephropathy
    Allen T.J.
    Cooper M.E.
    Lan H.Y.
    [J]. Current Diabetes Reports, 2004, 4 (6) : 435 - 440
  • [2] Add-on anti-TGF-β antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat
    Benigni, A
    Zoja, C
    Corna, D
    Zatelli, C
    Conti, S
    Campana, M
    Gagliardini, E
    Rottoli, D
    Zanchi, C
    Abbate, M
    Ledbetter, S
    Remuzzi, G
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07): : 1816 - 1824
  • [3] BOHLE A, 1991, PATHOL RES PRACT, V187, P251
  • [4] BOWER G, 1980, LAB INVEST, V43, P333
  • [5] Role of leptin and melanocortin signaling in uremia-associated cachexia
    Cheung, W
    Yu, PX
    Little, BM
    Cone, RD
    Marks, DL
    Mak, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (06) : 1659 - 1665
  • [6] Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury
    Chow, F
    Ozols, E
    Nikolic-Paterson, DJ
    Atkins, RC
    Tesch, GH
    [J]. KIDNEY INTERNATIONAL, 2004, 65 (01) : 116 - 128
  • [7] Nephron number and renal risk in hypertension and diabetes
    Gross, ML
    Amann, K
    Ritz, E
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 : S27 - S29
  • [8] GLOMERULAR-LESIONS IN UNILATERAL NEPHRECTOMIZED AND DIABETIC (UN-D) MICE
    KUME, E
    DOI, C
    ITAGAKI, S
    NAGASHIMA, Y
    DOI, K
    [J]. JOURNAL OF VETERINARY MEDICAL SCIENCE, 1992, 54 (06) : 1085 - 1090
  • [9] Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease
    Ninichuk, V
    Gross, O
    Reichel, C
    Khandoga, A
    Pawar, RD
    Ciubar, R
    Segerer, S
    Belemezova, E
    Radomska, E
    Luckow, B
    de Lema, GP
    Murphy, PM
    Gao, JL
    Henger, A
    Kretzler, M
    Horuk, R
    Weber, M
    Krombach, F
    Schlöndorff, D
    Anders, HJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (04): : 977 - 985
  • [10] ZEIER M, 1992, J AM SOC NEPHROL, V3, P1119